Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-01-12

Clinical Trial Update: Effects of Buspirone in Opiate Withdrawal [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluated the effects of buspirone on opiate withdrawal in individuals with heroin dependence; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Buspirone (buspirone)

Snippet

Sponsor: National Institute on Drug Abuse (NIDA) | Conditions: Heroin Dependence | Phase 4 | Status: COMPLETED